Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

CONTEXT: Circulating concentration of lipoprotein(a) (Lp[a]), a large glycoprotein attached to a low-density lipoprotein-like particle, may be associated with risk of coronary heart disease (CHD) and stroke. OBJECTIVE: To assess the relationship of Lp(a) concentration with risk of major vascular and...

Full description

Bibliographic Details
Main Authors:	Erqou, S, Kaptoge, S, Perry, P, Di Angelantonio, E, Thompson, A, White, I, Marcovina, S, Collins, R, Thompson, S, Danesh, J
Format:	Journal article
Language:	English
Published:	2009

Similar Items

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
by: Kaptoge, S, et al.
Published: (2010)

Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality
by: Parish, S, et al.
Published: (2010)

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
by: Thompson, A, et al.
Published: (2010)

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
by: Heart Protection Study Collaborative Group
Published: (2010)

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
by: Danesh, J, et al.
Published: (2005)

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
by: Danesh, J, et al.
Published: (2000)

Risk assessment in coronary patients undergoing abdominal nonvascular surgery
by: Karapandzic Vesna, et al.
Published: (2009-12-01)

Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis.
by: Lathan Liou, et al.
Published: (2020-01-01)

Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
by: Lisandro D. Colantonio, et al.
Published: (2022-06-01)

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men.
by: Emberson, JR, et al.
Published: (2010)

The Fate of Nonvascularized Fat Grafts: Histological and Bioluminescent Study
by: Ataru Sunaga, MD, et al.
Published: (2013-09-01)

Nonvascular retinal imaging markers of preclinical Alzheimer's disease
by: Peter J. Snyder, et al.
Published: (2016-01-01)

Major lipids, apolipoproteins, and risk of vascular disease.
by: Di Angelantonio, E, et al.
Published: (2009)

Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.
by: Emanuele Di Angelantonio, et al.
Published: (2007-09-01)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
by: Hopewell, J, et al.
Published: (2011)

Role of percutaneous nonvascular Interventional Radiology treatments in musculoskeletal lesions
by: Deep Narayan Srivastava
Published: (2016-01-01)

Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses
by: Sofianopoulou, E, et al.
Published: (2021)

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
by: Stefania Lamon-Fava, et al.
Published: (2011-06-01)

The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
by: Kent, S, et al.
Published: (2016)

Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults
by: Zhuang, Z, et al.
Published: (2021)

Intercalary diaphysometafisary humeral reconstruction with nonvascularized peroneal graft and external fixation
by: Yulay Enrique Hernández-Rojas, et al.
Published: (2023-07-01)

Donor Site Morbidity of Nonvascularized Bone Graft: A Systematic Review
by: Lilies Dwi Sulistyani, et al.
Published: (2023-06-01)

Comparison of the outcomes of vascularized and nonvascularized bone grafting in treatment of scaphoid nonunion
by: Ali Tabrizi, et al.
Published: (2022-01-01)

Reconstruction of mandibular defects using nonvascularized autogenous bone graft in Nigerians
by: Kizito Chioma Ndukwe, et al.
Published: (2014-01-01)

Results of nonvascular fibula grafting with osteosynthesis in neglected fracture neck of femur
by: Nirmal Chandra Mohapatra, et al.
Published: (2014-01-01)

Association of CETP gene variants with risk for vascular and nonvascular diseases among Chinese adults
by: Millwood, I, et al.
Published: (2017)

Efficiency and safety of varying the frequency of whole blood donation: randomised trial of 45,000 donors
by: Di Angelantonio, E, et al.
Published: (2017)

Lymphangiogenesis after nonvascularized lymph node transplantation: Lymphangiographic findings in mice and minipigs
by: Kyoung Min Kim, et al.
Published: (2023-01-01)

Exposed Artificial Plate Covered With Perifascial Areolar Tissue as a Nonvascularized Graft
by: Tomoyuki Ito, MD, et al.
Published: (2019-02-01)

Chronic infections and coronary heart disease: is there a link?
by: Danesh, J, et al.
Published: (1997)

Coronary heart disease and stroke mortality trends in Brazil 2000-2018.
by: Patrícia Vasconcelos Leitão Moreira, et al.
Published: (2021-01-01)

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
by: Jin-Ming Cen, et al.
Published: (2015-06-01)

Effect of the Gupta Score on Pre-operative Cardiology Consultation Requests in Noncardiac Nonvascular Surgery
by: Funda Atar, et al.
Published: (2023-12-01)

Transplantation of Nonvascularized Kidney Tissue Fragments into the Rat Liver with the Aim of Preserving Renal Function
by: Shin Enosawa, et al.
Published: (2004-05-01)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
by: Zewinger, S, et al.
Published: (2017)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
by: Zewinger, S, et al.
Published: (2017)

Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.
by: Kaptoge, S, et al.
Published: (2007)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
by: Farrer, M, et al.
Published: (1993)

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
by: E. Sverre, et al.
Published: (2023-06-01)

Paraoxonase polymorphisms and coronary heart disease - Reply
by: Wheeler, J, et al.
Published: (2004)